RCC2 contributes to tumor invasion and chemoresistance to cisplatin in hepatocellular carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology
Link
http://link.springer.com/content/pdf/10.1007/s13577-020-00353-7.pdf
Reference28 articles.
1. Mizejewski GJ. Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary. J Hepatocell Carcinoma. 2016;3:37–40.
2. Thompson H. Cancer of the liver, esophagus, and nasopharynx. J Clin Pathol. 1988;41:359–459.
3. Chi HC, Chen SL, Cheng YH, et al. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway. Cell Death Dis. 2016;7:e2324.
4. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients (review). Cochrane Database Syst Rev. 2006;19:CD005037.
5. Amichetti M. Editorial hot topic: the association of radiotherapy and chemotherapy (guest editor: Maurizio Amichetti). Curr Drug Ther. 2010;5:151–251.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. circRNA-0015004 act as a ceRNA to promote RCC2 expression in hepatocellular carcinoma;Scientific Reports;2024-07-23
2. Hsa-circRNA-0015004 promotes hepatocellular carcinoma development via miRNA-330-3p/RCC2 axis;2024-04-19
3. A data-adaptive methods in detecting exogenous methyltransferase accessible chromatin in human genome using nanopore sequencing;Bioinformatics;2024-04-13
4. Multi-ancestry genome-wide meta-analysis identifies novel basal cell carcinoma loci and shared genetic effects with squamous cell carcinoma;Communications Biology;2024-01-05
5. PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer;International Journal of Biological Sciences;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3